414 related articles for article (PubMed ID: 14529839)
1. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
[TBL] [Abstract][Full Text] [Related]
2. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
3. Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.
Huang X; Wilber AC; Bao L; Tuong D; Tolar J; Orchard PJ; Levine BL; June CH; McIvor RS; Blazar BR; Zhou X
Blood; 2006 Jan; 107(2):483-91. PubMed ID: 16189271
[TBL] [Abstract][Full Text] [Related]
4. Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo.
Keravala A; Liu D; Lechman ER; Wolfe D; Nash JA; Lampe DJ; Robbins PD
Hum Gene Ther; 2006 Oct; 17(10):1006-18. PubMed ID: 16989604
[TBL] [Abstract][Full Text] [Related]
5. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
[TBL] [Abstract][Full Text] [Related]
6. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
Riu E; Grimm D; Huang Z; Kay MA
Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
[TBL] [Abstract][Full Text] [Related]
7. Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals.
Hausl M; Zhang W; Voigtländer R; Müther N; Rauschhuber C; Ehrhardt A
Curr Gene Ther; 2011 Oct; 11(5):363-74. PubMed ID: 21888620
[TBL] [Abstract][Full Text] [Related]
8. Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system.
Belur LR; Frandsen JL; Dupuy AJ; Ingbar DH; Largaespada DA; Hackett PB; Scott McIvor R
Mol Ther; 2003 Sep; 8(3):501-7. PubMed ID: 12946324
[TBL] [Abstract][Full Text] [Related]
9. Transgene Expression and Transposition Efficiency of Two-Component Sleeping Beauty Transposon Vector Systems Utilizing Plasmid or mRNA Encoding the Transposase.
Tschorn N; van Heuvel Y; Stitz J
Mol Biotechnol; 2023 Aug; 65(8):1327-1335. PubMed ID: 36547824
[TBL] [Abstract][Full Text] [Related]
10. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.
Yant SR; Meuse L; Chiu W; Ivics Z; Izsvak Z; Kay MA
Nat Genet; 2000 May; 25(1):35-41. PubMed ID: 10802653
[TBL] [Abstract][Full Text] [Related]
11. Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
Sumiyoshi T; Holt NG; Hollis RP; Ge S; Cannon PM; Crooks GM; Kohn DB
Hum Gene Ther; 2009 Dec; 20(12):1607-26. PubMed ID: 19689196
[TBL] [Abstract][Full Text] [Related]
12. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression.
Score PR; Belur LR; Frandsen JL; Geurts JL; Yamaguchi T; Somia NV; Hackett PB; Largaespada DA; McIvor RS
Mol Ther; 2006 Mar; 13(3):617-24. PubMed ID: 16356773
[TBL] [Abstract][Full Text] [Related]
13. Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.
Hausl MA; Zhang W; Müther N; Rauschhuber C; Franck HG; Merricks EP; Nichols TC; Kay MA; Ehrhardt A
Mol Ther; 2010 Nov; 18(11):1896-906. PubMed ID: 20717103
[TBL] [Abstract][Full Text] [Related]
14. Hyperactive transposase mutants of the Sleeping Beauty transposon.
Baus J; Liu L; Heggestad AD; Sanz S; Fletcher BS
Mol Ther; 2005 Dec; 12(6):1148-56. PubMed ID: 16150650
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer into genomes of human cells by the sleeping beauty transposon system.
Geurts AM; Yang Y; Clark KJ; Liu G; Cui Z; Dupuy AJ; Bell JB; Largaespada DA; Hackett PB
Mol Ther; 2003 Jul; 8(1):108-17. PubMed ID: 12842434
[TBL] [Abstract][Full Text] [Related]
16. Development of hyperactive sleeping beauty transposon vectors by mutational analysis.
Zayed H; Izsvák Z; Walisko O; Ivics Z
Mol Ther; 2004 Feb; 9(2):292-304. PubMed ID: 14759813
[TBL] [Abstract][Full Text] [Related]
17. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
18. A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase.
Ehrhardt A; Xu H; Huang Z; Engler JA; Kay MA
Mol Ther; 2005 May; 11(5):695-706. PubMed ID: 15851008
[TBL] [Abstract][Full Text] [Related]
19. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
Miao CH; Thompson AR; Loeb K; Ye X
Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
[TBL] [Abstract][Full Text] [Related]
20. Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.
Huang X; Haley K; Wong M; Guo H; Lu C; Wilber A; Zhou X
Hum Gene Ther; 2010 Nov; 21(11):1577-90. PubMed ID: 20528476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
